CBOA
TEVA icon

Commonwealth Bank of Australia’s Teva Pharmaceuticals TEVA Stock Holding History

Commonwealth Bank of Australia’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,750
Closed -$14K – 851
2019
Q2 		$14K Buy
1,750
+743
+74% +$8.96K ﹤0.01% 1074
2019
Q1 		$14K Buy
1,007
+100
+11% +$1.76K ﹤0.01% 1063
2018
Q4 		$12K Buy
907
+110
+14% +$2.25K ﹤0.01% 1072
2018
Q3 		$16K Sell
797
-100
-11% -$2.32K ﹤0.01% 1081
2018
Q2 		$20K Buy
897
+302
+51% +$6.16K ﹤0.01% 744
2018
Q1 		$9K Hold
595
– – ﹤0.01% 779
2017
Q4 		$10K Sell
595
-16
-3% -$241 ﹤0.01% 785
2017
Q3 		$9K Sell
611
-1,330
-69% -$29.9K ﹤0.01% 776
2017
Q2 		$63K Buy
1,941
+606
+45% +$18.8K ﹤0.01% 782
2017
Q1 		$43K Buy
+1,335
New +$45.6K ﹤0.01% 815
2014
Q2 		– Sell
-93,243
Closed -$4.93M – 1012
2014
Q1 		$4.93M Sell
93,243
-24,838
-21% -$1.15M 0.03% 442
2013
Q4 		$4.73M Sell
118,081
-42,726
-27% -$1.68M 0.03% 429
2013
Q3 		$6.08M Sell
160,807
-8,788
-5% -$343K 0.04% 353
2013
Q2 		$6.65M Buy
+169,595
New +$6.6M 0.05% 311

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Commonwealth Bank of Australia's TEVA Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 1,750 shares — an estimated $14K sold.

Commonwealth Bank of Australia first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $6.65M in Q2 2013. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 1,750 Teva Pharmaceuticals shares in Q3 2019, an estimated $14K.
  • Commonwealth Bank of Australia first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Commonwealth Bank of Australia's Teva Pharmaceuticals position peaked at $6.65M in Q2 2013.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.